Endothelial nitric oxide synthase gene polymorphism in the Indian and Mestizo populations of Mexico

Human Biology

Volumn 75, Issue 1, 2003, Pages 91-96

  Rosas Vargas, Haydeé ^a   Flores Segura, Adrián ^a   Guizada Claure, Boris ^a   Vargas Alarcón, Gilberto ^b   Granados, Julio ^c   Salamanca, Fabio ^a   Coral Vázquez, Ramón ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Cardiovascular disease; Genetics; Latin America; NOS polymorphism

Indexed keywords

ASPARTIC ACID; ENDONUCLEASE; GLUTAMIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; THYMIDINE;

ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CAUCASIAN; DNA POLYMORPHISM; ENDOTHELIUM CELL; ETHNOLOGY; EXON; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENOTYPE; HUMAN; INDIAN; MEXICO; NORMAL HUMAN; POPULATION GENETICS; RESTRICTION MAPPING; VASODILATATION;

BIKINIA LE-TESTUI;

EID: 0037309403     PISSN: 00187143     EISSN: None     Source Type: Journal    
DOI: 10.1353/hub.2003.0027     Document Type: Article

References (16)

1. Alderton, W.K., C.E. Cooper, and R.G. Knowles. 2001. Nitric oxide synthases: Structure, function and inhibition. Biochem. J. 357:593-615.
2. Cai, H., D.E.L. Wilcken, and X.L. Wang. 1999. The Glu298Asp (894G-T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J. Molec. Med. 77:511-514.
3. Cavalli-Sforza, L. 1997. Genes, peoples, and languages. Proc. Natl. Acad. Sci. USA 94:7719-7724.
4. Fairchild, T.A., D. Fulton, J.T. Fontana et al. 2001. Acidic hydrolysis as a mechanism for the cleavage of the Glu298Asp variant of human endothelial nitric oxide synthase. J. Biol. Chem. 276:26674-26679.
5. Gamboa, R., G. Hernández-Pacheco, R. Hesiquio. 2000. Apolipoprotein E polymorphism in the Indian and Mestizo populations of Mexico. Hum. Biol. 62:975-981.
6. Hingorani, A.D., C.F. Liang, J. Fatibene et al. 1999. A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100:1515-1520.
7. Jachymova, M., K. Horky, J. Bultas et al. 2001. Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem. Biophys. Res. Comm. 284:426-430.
8. Liao, Y.L., K. Saku, J. Ou. 1999. A missense mutation of the nitric oxide synthase (eNOS) gene (Glu298Asp) in five patients with coronary artery disease: Case reports. Angiology 50:671-676.
9. Lisker, R., E. Ramirez, R. Perez-Briceño et al. 1990. Gene frequencies and admixture estimates in four Mexican urban centers. Hum. Biol. 62:791-801.
10. Marsden, P.A., H.H. Heng, S.W. Scherer et al. 1993. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268:17478-17488.
11. Moncada, S., R.N.J. Palmer, and E.A. Higgs. 1991. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43:109-142.
12. Nathan, C., and Q.W. Xi. 1994. Nitric oxide synthases: Roles, tolls, and controls. Cell 78:915-918.
13. Shimasaki, Y., H. Yashue, M. Yoshimura et al. 1998. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J. Am. Coll. Cardiol. 31:1506-1510.
14. Shoji, M., S. Tsutaya, R. Saito et al. 2000. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sciences 66:2557-2562.
15. Tesauro, M., W.C. Thompson, P. Rogliani et al. 2000. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl. Acad. Sci. USA 97:2832-2835.
16. Yoshimura, M., H. Yasue, M. Nakayama et al. 1998. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum. Genet. 103:65-69.